We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
551
Teladoc Health
TDOC
$1.21B
$103K 0.01%
+4,600
New +$124K
MSCC
552
DELISTED
Microsemi Corp
MSCC
$103K 0.01%
3,124
+1,353
+76% +$44K
CRC
553
DELISTED
California Resources Corporation
CRC
$103K 0.01%
3,962
+2,046
+107% +$80.2K
NEU icon
554
NewMarket
NEU
$8.21B
$102K 0.01%
287
-1,464
-84% -$593K
TSM icon
555
TSMC
TSM
$2.17T
$102K 0.01%
4,900
+4,800
+4,800% +$101K
ARNA
556
DELISTED
Arena Pharmaceuticals Inc
ARNA
$102K 0.01%
+5,341
New +$181K
CLNE icon
557
Clean Energy Fuels
CLNE
$410M
$101K 0.01%
22,526
+4,310
+24% +$22.3K
WBMD
558
DELISTED
WebMD Health Corp.
WBMD
$101K 0.01%
2,529
+2,417
+2,158% +$102K
RAX
559
DELISTED
Rackspace Hosting Inc
RAX
$101K 0.01%
+4,087
New +$132K
THOR
560
DELISTED
THORATEC CORPORATION
THOR
$101K 0.01%
1,594
+1,167
+273% +$69.3K
CW icon
561
Curtiss-Wright
CW
$26.4B
$100K 0.01%
1,600
+300
+23% +$20.2K
IBCP icon
562
Independent Bank Corp
IBCP
$793M
$100K 0.01%
6,761
+6,671
+7,412% +$94K
IMAX icon
563
IMAX
IMAX
$2.73B
$100K 0.01%
2,964
-552
-16% -$19.1K
MFIN icon
564
Medallion Financial
MFIN
$250M
$100K 0.01%
13,193
+12,900
+4,403% +$102K
NICE icon
565
Nice
NICE
$5.69B
$100K 0.01%
1,772
+1,626
+1,114% +$102K
NOC icon
566
Northrop Grumman
NOC
$80.7B
$100K 0.01%
600
-498
-45% -$83.5K
AIMT
567
DELISTED
Aimmune Therapeutics
AIMT
$100K 0.01%
+3,964
New +$92.7K
ISRL
568
DELISTED
Isramco Inc
ISRL
$100K 0.01%
1,006
+810
+413% +$104K
AUB icon
569
Atlantic Union Bankshares
AUB
$6.02B
$99K 0.01%
4,107
+3,676
+853% +$87.3K
EGBN icon
570
Eagle Bancorp
EGBN
$849M
$99K 0.01%
2,172
-112
-5% -$4.92K
KPTI icon
571
Karyopharm Therapeutics
KPTI
$44.2M
$99K 0.01%
628
+517
+466% +$138K
KRNY icon
572
Kearny Financial
KRNY
$604M
$99K 0.01%
8,629
+8,617
+71,808% +$98.6K
MPC icon
573
Marathon Petroleum
MPC
$84B
$99K 0.01%
+2,141
New +$110K
PEBO icon
574
Peoples Bancorp
PEBO
$1.48B
$99K 0.01%
4,723
+2,967
+169% +$64.9K
WSBF icon
575
Waterstone Financial
WSBF
$375M
$99K 0.01%
7,380
+6,663
+929% +$87.1K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.